Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Discovery about fertilization points way to possible malaria vaccine

Discovery about fertilization points way to possible malaria vaccine

March 26, 2008

International investigations of an organism that one
UT Southwestern Medical Center researcher calls a "silly little green scum" have led to key insights into the basic mechanisms of reproduction.

The findings may help explain why species can almost never interbreed, and also point to a possible way to thwart the spread of malaria, a disease that kills about 1 million people each year, primarily children in sub-Saharan Africa.




In a study appearing online today and to be published in the April 14 issue of the journal Genes and Development, researchers from UT Southwestern have found that sexual reproduction begins with a two genetically different steps: First, two reproductive cells must first latch onto each other with one protein, and secondly, they must fuse their membranes to form a single cell using a different protein.

The UT Southwestern scientists collaborated with malaria experts at Imperial College London and found that the parasite causing the disease also uses this two-step process. When they blocked "male" and "female" malarial cells from fusing, spread of the mosquito-borne disease was stopped.

Their work started with a single-celled green alga nicknamed Chlamy (pronounced "clammy"), short for Chlamydomonas. This harmless organism, widely found in soil and water, is easy to grow and study under laboratory conditions.

"A silly little green scum has led us to an exciting new vaccine target for malaria," said Dr. William Snell, professor of cell biology at UT Southwestern and co-senior author of the study.

Understanding fertilization in microorganisms may lead to a new type of vaccine, called an "altruistic vaccine," Dr. Snell said. There is no vaccine to prevent malaria, but in the future, vaccinating an infected person to prevent the parasitic cells from completing the fusion step might stop the disease from passing to others.

Although the study involved only single-celled organisms, Dr. Snell said that the use of two different proteins in the two-step fertilization process may be the case in all species. The gene controlling whether egg and sperm can bind would be unique to each species, while the gene for the second step - fusing into a single cell - could be more universal. For example, the researchers found that HAP2, the gene that controlled whether cells fused, is also present in agriculturally important crops such as corn and wheat.

For the parasite that causes malaria, fusion is controlled by a gene not found in mammals, so blocking this step might prove effective in stanching the spread of the disease without harming humans, Dr. Snell said.

The UT Southwestern researchers initially were interested in general methods of reproduction, which are often studied in Chlamy. This single-celled organism can reproduce sexually, not with egg and sperm, but rather with some cells roughly corresponding to "male" and others to "female."

After realizing that Plasmodium species, including the one that causes malaria in humans, also use "male" and "female" cells to reproduce, Dr. Snell contacted malaria researchers at Imperial College London to test whether HAP2 might be involved in reproduction in that organism and in the spread of malaria.

The British researchers found that blocking HAP2 in Plasmodium cells stops the fusing step. When mutant Plasmodium organisms lacking HAP2 were injected into mice, mosquitoes that bit the mice did not become infected with Plasmodium and therefore could not spread the infection to other mice. This indicates that without HAP2, Plasmodium could not reproduce in a mosquito's gut, a vital step in the cycle of infection.

In addition to its applicability in fighting disease, the latest study confirms a theory about why different species can't interbreed, Dr. Snell said. There are rare exceptions in closely related species such as horses and donkeys, which can interbreed to create mules, or lions and tigers that can mix to form ligers, but such hybrids are sterile.

If the first step in reproduction, binding of egg and sperm, is controlled by a single gene per species, then the binding step would serve as a gatekeeper to prevent incompatible cells from getting close, Dr. Snell said. Evolutionarily, this scheme makes sense, he said, because it would take only a mutation in the single gene that controls egg-sperm binding to create a new species.

"There has been a lot of speculation about species-specific egg-sperm binding and fusion and whether the two steps involve the same or different proteins, but no one had the molecules to show this," Dr. Snell said. "We now have those molecules to show that a new species wouldn't have to reinvent the wheel to control fusion."

Other UT Southwestern researchers involved in the study were first author Dr. Yanjie Liu and Dr. Jue Ning, both postdoctoral researchers in cell biology; Dr. Jimin Pei, postdoctoral researcher in biochemistry; and Dr. Nick Grishin, associate professor of biochemistry.

Researchers from Imperial College London, University of Nottingham, The Wellcome Trust Sanger Institute and the University of California, Irvine, also participated in the study.

The work was supported by the National Institutes of Health, the London-based Medical Research Council, the Wellcome Trust, the Lister Institute of Preventive Medicine, the Swedish Research Council, and the Biology and Pathology of Malaria Parasite Network of Excellence of the European Commission.

Visit http://www.utsouthwestern.org/infectiousdiseases to learn more about
UT Southwestern's clinical services in infectious diseases.

The University of Texas Southwestern Medical Center at Dallas



Related Malaria Vaccine Current Events and Malaria Vaccine News Articles Malaria Vaccine Current Events and Malaria Vaccine News RSS Malaria Vaccine Current Events and Malaria Vaccine News RSS
PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines
Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa.

UM School of Medicine researchers find extreme genetic variability in malaria parasite
Researchers at the University of Maryland School of Medicine Center for Vaccine Development (CVD) have charted the extreme genetic differences that occur over time in the most dangerous malaria parasite in the world.

First genetically-engineered malaria vaccine to enter human trials
Walter and Eliza Hall Institute scientists have created a weakened strain of the malaria parasite that will be used as a live vaccine against the disease.

Vaccine Blocks Malaria Transmission in Lab Experiments
Researchers at the Johns Hopkins Malaria Research Institute have for the first time produced a malarial protein (Pfs48/45) in the proper conformation and quantity to generate a significant immune response in mice and non-human primates for use in a potential transmission-blocking vaccine.

Promising trials of malaria vaccine lead to calls for Phase 3 development
Experts are recommending that a malaria vaccine progress to Phase 3 trials following the successful trial of the RTS, S/AS01E malaria vaccine among 5-17 month old children in Korogwe, Tanzania and coastal Kenya, which is reported today in the New England Journal of Medicine (NEJM).

Researchers characterize potential protein targets for malaria vaccine
Researchers from Nijmegen and Leiden have now characterized a large number of parasite proteins that may prove useful in the development of a human malaria vaccine.

Early promising results in malaria vaccine trial in Mali
A small clinical trial conducted by an international team of researchers in Mali has found that a candidate malaria vaccine was safe and elicited strong immune responses in the 40 Malian adults who received it.

Case Western Reserve University School of Medicine researchers have evidence a vaccine against malaria will reduce infection and disease rates
Today, researchers at the Case Western Reserve University School of Medicine's Center for Global Health & Diseases published data potentially having a strong effect on the three billion people exposed to malaria every year.

New nanoparticle vaccine is more effective but less expensive
Good news for public health: Bioengineering researchers from the EPFL in Lausanne, Switzerland, have developed and patented a nanoparticle that can deliver vaccines more effectively, with fewer side effects, and at a fraction of the cost of current vaccine technologies.

Novel approach for rapid identification and development of malaria vaccines
Malaria is the world's most frequent parasitic disease, affecting more than 100 countries in the tropical zones, mostly in Africa, and 40% of the world population, with more than a million deaths per year.
More Malaria Vaccine Current Events and Malaria Vaccine News Articles
The Elusive Malaria Vaccine: Miracle or Mirage?

The Elusive Malaria Vaccine: Miracle or Mirage?
by Irwin W. Sherman (Author)

Chronicling a 100-year quest, this book tells the fascinating story of the hunt for the still-elusive malaria vaccine. Its clear, engaging style makes the book accessible to a general audience and brings to life all the drama of the hunt, celebrating the triumphs and documenting the failures. The author captures the controversies, missteps, wars of words, stolen ideas, and clashes of ego as researchers around the world compete to develop the first successful malaria vaccine. "The Elusive Malaria Vaccine: Miracle or Mirage?" is based on author Irwin W. Sherman's thorough investigation of the scientific literature as well as his first-hand interviews with today's pioneers in malaria vaccine research. As a result, the book offers remarkable insights into the keys to a successful malaria...

Molecular Immunological Considerations in Malaria Vaccine Development

Molecular Immunological Considerations in Malaria Vaccine Development
by Michael F. Good (Author), Allan J. Saul (Author)

Some of the world's leading research scientists in the field have contributed to this new book on malaria vaccine development. The book examines various strategies being pursued against the different stages of the parasite (the sporozoite, asexual erythrocytic stages, and sexual stages). It describes vaccines that combat the parasite directly, vaccines aimed at preventing disease, vaccines based on attenuated parasites, and vaccines based on small, carefully defined synthetic peptides. The book provides a compendium of current approaches, lists of preferred antigens, and the results of vaccine trials to date. Molecular immunology involved with both the natural immune response to parasites and with the constraints on inducing immunity are emphasized throughout the book. Views on how...

Malaria: Malaria. Mosquito control, Malaria prophylaxis, Malaria vaccine, Antimalarial drug, History of malaria, Evolution, Natural selection

Malaria: Malaria. Mosquito control, Malaria prophylaxis, Malaria vaccine, Antimalarial drug, History of malaria, Evolution, Natural selection
by John McBrewster (Editor), Frederic P. Miller (Editor), Agnes F. Vandome (Editor)

Malaria. Mosquito control, Malaria prophylaxis, Malaria vaccine, Antimalarial drug, History of malaria, Evolution, Natural selection, Diseases of poverty, Tropical disease, Sterile insect technique, Globalization and disease, Eradication of infectious diseases, The Global Fund to Fight AIDS, Tuberculosis and Malaria

The demand for a malaria vaccine: evidence from Ethiopia [An article from: Journal of Development Economics]

The demand for a malaria vaccine: evidence from Ethiopia [An article from: Journal of Development Economics]
by M.L. Cropper (Author), M. Haile (Author), J. Lampietti (Author), C. Poulos (Author), W (Author)

This digital document is a journal article from Journal of Development Economics, published by Elsevier in 2004. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.

Description:
This study measures the monetary value households place on preventing malaria in Tigray, Ethiopia. We estimate a household demand function for a hypothetical malaria vaccine and compute the value of preventing malaria as the household's maximum willingness to pay to provide vaccines for all family members. This is contrasted with the traditional costs of illness (medical costs and lost productivity). Our results indicate that the value of preventing malaria with vaccines is about US$36 per household...

  Malaria Vaccine Development: A Multi-Immune Response Approach
b



Malaria: Waiting for the Vaccine

Malaria: Waiting for the Vaccine
by G. A. T. Targett (Editor)

Malaria affects very large populations in tropical and sub-tropical areas of the world and the situation is now exacerbated by a growing resistance to drugs and insecticides by parasite and mosquito, respectively. Addresses the problem of public health management at the individual and community level, including the use and supply of drugs currently available as well as the economics of already strained health programs. The current status of vaccine development is assessed and recommendations are made for future research.

  Pnas (Proceeding of the National Academy of Sciences) February 16, 1999: Origin and Evolution of the ''Spanish'' Flu; Multistage Malaria Vaccine
by National Academy of Sciences (Author)



Battling Malaria: Strengthening the U.S. Military Malaria Vaccine Program

Battling Malaria: Strengthening the U.S. Military Malaria Vaccine Program
by Committee on U.S. Military Malaria Vaccine Research - A Program Review (Author), Patricia M. Graves (Editor), Myron M. Levine (Editor)



  The Conference on Malaria in Africa - Proceedings : Practical Considerations on Malaria Vaccines and Clinical Trials
by American Institute of Biological Sciences (Publisher)



  Malaria: An entry from Thomson Gale's Gale Encyclopedia of Alternative Medicine
by Mai Tran (Author)

The term “Alternative Medicine” encompasses many forms, and elicits at least as many opinions. This authoritative, objective set is in tune with the subjects that matter to students and researchers, presenting four volumes of current, unbiased information on alternative and complementary medical practices. Covering all aspects of the subject—Therapies, Conditions/Diseases, Herbs/Plants and People—the “Gale Encyclopedia of Alternative Medicine” identifies 150 types of alternative medicine being practiced today, including reflexology, acupressure, acupuncture, chelation therapy, kinesiology, yoga, chiropractic, Feldenkrais, polarity therapy, detoxification, naturopathy, Chinese medicine, biofeedback, Ayurveda and osteopathy. For the practitioner or interested patient, there...

© 2009 BrightSurf.com